Table of Contents Author Guidelines Submit a Manuscript
Research Article
International Journal of Endocrinology
Volume 2017, Article ID 4827469, 1 page
https://doi.org/10.1155/2017/4827469
Corrigendum

Corrigendum to “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort”

1Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA
2Wade Outcomes Research and Consulting, 358 South 700 East, Suite B432, Salt Lake City, UT 84102, USA
3Q.D. Research, Inc., 8789 Auburn Folsom Road, Suite C501, Granite Bay, CA 95746, USA
4Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, 10 S. Pine Street, MSTF 8-34, Baltimore, MD 21201, USA

Correspondence should be addressed to Nicole Yurgin; moc.negma@nigruyn

Received 18 June 2017; Accepted 26 July 2017; Published 25 October 2017

Copyright © 2017 Nicole Yurgin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In the article titled “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort” [1], there was an error regarding the FRAX® tool, which should be clarified as follows:

The article notes “The WHO fracture risk assessment tool (FRAX) is a computer-based algorithm that assesses fracture probability of men and women [1].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.

References

  1. N. Yurgin, S. Wade, S. Satram-Hoang, D. Macarios, and M. Hochberg, “Prevalence of fracture risk factors in postmenopausal women enrolled in the POSSIBLE US treatment cohort,” International Journal of Endocrinology, vol. 2013, Article ID 715025, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Ford, S. L. Norris, and S. R. Hill, “Clarifying WHO’s position on the FRAX® tool for fracture prediction,” Bulletin of the World Health Organization, vol. 94, no. 12, p. 862, 2016. View at Publisher · View at Google Scholar · View at Scopus